Patrick Joseph Kiel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Certifications & Licensure
- Board of Pharmacy Specialties (BPS) Oncology Pharmacy
- Board of Pharmacy Specialties (BPS) Pharmacotherapy
Education & Training
- Indiana University HealthResidency, 2007 - 2008
- Rush University Medical CenterResidency, 2006 - 2007
- Midwestern UniversityPharmD, 2006
Awards, Honors, & Recognition
- FHOPA HOPA, 2019
Publications & Presentations
PubMed
- 14 citationsEnasidenib: An Oral IDH2 Inhibitor for the Treatment of Acute Myeloid Leukemia.Rebecca A. Myers, Scott Wirth, Sherry Williams, Patrick J. Kiel
Journal of the Advanced Practitioner in Oncology. 2018-05-01 - 13 citationsEfficacy of Different Leuprolide Administration Schedules in Premenopausal Breast Cancer: A Retrospective ReviewDaniel C. Kendzierski, Bryan P. Schneider, Patrick J. Kiel
Clinical Breast Cancer. 2018-10-01 - 52 citationsExceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid CancerRevathi Kollipara, Bryan P. Schneider, Milan Radovich, Sunil Babu, Patrick J. Kiel
The Oncologist. 2017-10-01
Office
555 University Blvd
Indianapolis, IN 46202Phone+1 317-948-5324
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: